nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—SLC22A5—Dactinomycin—ocular cancer	0.73	0.798	CbGbCtD
Desipramine—ABCB1—Dactinomycin—ocular cancer	0.185	0.202	CbGbCtD
Desipramine—CHRM3—Metabolism—GNAQ—ocular cancer	4.02e-05	0.000471	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—GNAQ—ocular cancer	4.01e-05	0.00047	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—GNAQ—ocular cancer	3.92e-05	0.00046	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—GNAQ—ocular cancer	3.9e-05	0.000457	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—CDKN2B—ocular cancer	3.87e-05	0.000453	CbGpPWpGaD
Desipramine—SMPD1—Metabolism—AKT1—ocular cancer	3.73e-05	0.000437	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—GNA11—ocular cancer	3.72e-05	0.000436	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—E2F1—ocular cancer	3.71e-05	0.000435	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—GNA11—ocular cancer	3.71e-05	0.000434	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HDAC1—ocular cancer	3.7e-05	0.000433	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—GNA11—ocular cancer	3.65e-05	0.000427	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—GNA11—ocular cancer	3.64e-05	0.000427	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—GNA11—ocular cancer	3.64e-05	0.000426	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—GNA11—ocular cancer	3.63e-05	0.000425	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HDAC1—ocular cancer	3.62e-05	0.000424	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—GNA11—ocular cancer	3.62e-05	0.000424	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—GNA11—ocular cancer	3.58e-05	0.00042	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—E2F1—ocular cancer	3.55e-05	0.000416	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HDAC1—ocular cancer	3.54e-05	0.000414	CbGpPWpGaD
Desipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	3.53e-05	0.000413	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HDAC1—ocular cancer	3.52e-05	0.000412	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—GNAQ—ocular cancer	3.46e-05	0.000405	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—GNAQ—ocular cancer	3.45e-05	0.000404	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—GNAQ—ocular cancer	3.39e-05	0.000397	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—GNAQ—ocular cancer	3.39e-05	0.000397	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—GNAQ—ocular cancer	3.38e-05	0.000396	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—GNAQ—ocular cancer	3.37e-05	0.000395	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—GNAQ—ocular cancer	3.36e-05	0.000394	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—GNAQ—ocular cancer	3.33e-05	0.00039	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CDKN2B—ocular cancer	3.31e-05	0.000388	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CDKN2B—ocular cancer	3.24e-05	0.00038	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CDKN2B—ocular cancer	3.17e-05	0.000372	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CDKN2B—ocular cancer	3.15e-05	0.00037	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HDAC1—ocular cancer	3.11e-05	0.000364	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—HDAC1—ocular cancer	3.06e-05	0.000358	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HDAC1—ocular cancer	3.05e-05	0.000357	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—E2F1—ocular cancer	3.04e-05	0.000357	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HDAC1—ocular cancer	3.04e-05	0.000356	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HDAC1—ocular cancer	3.03e-05	0.000355	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HDAC1—ocular cancer	3e-05	0.000352	CbGpPWpGaD
Desipramine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	2.98e-05	0.000349	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—E2F1—ocular cancer	2.98e-05	0.000349	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—E2F1—ocular cancer	2.91e-05	0.000341	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—E2F1—ocular cancer	2.9e-05	0.000339	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—GNA11—ocular cancer	2.81e-05	0.000329	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CDKN2B—ocular cancer	2.78e-05	0.000326	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—GNA11—ocular cancer	2.74e-05	0.000321	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CDKN2B—ocular cancer	2.74e-05	0.000321	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CDKN2B—ocular cancer	2.73e-05	0.00032	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CDKN2B—ocular cancer	2.72e-05	0.000319	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CDKN2B—ocular cancer	2.72e-05	0.000318	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CDKN2B—ocular cancer	2.69e-05	0.000315	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—EP300—ocular cancer	2.68e-05	0.000313	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—GNAQ—ocular cancer	2.61e-05	0.000306	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—GNA11—ocular cancer	2.59e-05	0.000303	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—E2F1—ocular cancer	2.56e-05	0.000299	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—GNAQ—ocular cancer	2.55e-05	0.000299	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—EP300—ocular cancer	2.53e-05	0.000296	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—E2F1—ocular cancer	2.51e-05	0.000295	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—E2F1—ocular cancer	2.51e-05	0.000294	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—E2F1—ocular cancer	2.5e-05	0.000293	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—E2F1—ocular cancer	2.49e-05	0.000292	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—E2F1—ocular cancer	2.47e-05	0.000289	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—GNAQ—ocular cancer	2.4e-05	0.000282	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—MDM2—ocular cancer	2.24e-05	0.000263	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GNA11—ocular cancer	2.19e-05	0.000257	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—MDM2—ocular cancer	2.15e-05	0.000252	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—ocular cancer	2.11e-05	0.000247	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—HRAS—ocular cancer	2.08e-05	0.000244	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—CDKN1B—ocular cancer	2.05e-05	0.00024	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GNAQ—ocular cancer	2.04e-05	0.000239	CbGpPWpGaD
Desipramine—CHRM4—GPCR downstream signaling—AKT1—ocular cancer	2.02e-05	0.000237	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—HRAS—ocular cancer	1.99e-05	0.000234	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—CDKN1B—ocular cancer	1.96e-05	0.00023	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—CCND1—ocular cancer	1.95e-05	0.000229	CbGpPWpGaD
Desipramine—CHRM5—GPCR downstream signaling—AKT1—ocular cancer	1.94e-05	0.000227	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—CDKN1A—ocular cancer	1.89e-05	0.000221	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—CCND1—ocular cancer	1.87e-05	0.000219	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MDM2—ocular cancer	1.84e-05	0.000215	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—AKT1—ocular cancer	1.84e-05	0.000215	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—CDKN1A—ocular cancer	1.81e-05	0.000212	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MDM2—ocular cancer	1.8e-05	0.000211	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—EP300—ocular cancer	1.8e-05	0.000211	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—AKT1—ocular cancer	1.76e-05	0.000206	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MDM2—ocular cancer	1.76e-05	0.000206	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MDM2—ocular cancer	1.75e-05	0.000205	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—EP300—ocular cancer	1.72e-05	0.000202	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—HRAS—ocular cancer	1.71e-05	0.0002	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GNA11—ocular cancer	1.69e-05	0.000198	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CDKN1B—ocular cancer	1.68e-05	0.000197	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—EP300—ocular cancer	1.68e-05	0.000197	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—HRAS—ocular cancer	1.67e-05	0.000196	CbGpPWpGaD
Desipramine—ADRB1—GPCR downstream signaling—AKT1—ocular cancer	1.66e-05	0.000195	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.64e-05	0.000193	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CDKN1B—ocular cancer	1.64e-05	0.000192	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—HRAS—ocular cancer	1.63e-05	0.000191	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—HRAS—ocular cancer	1.63e-05	0.00019	CbGpPWpGaD
Desipramine—ADRB2—GPCR downstream signaling—AKT1—ocular cancer	1.62e-05	0.00019	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—AKT1—ocular cancer	1.62e-05	0.000189	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CDKN1B—ocular cancer	1.61e-05	0.000188	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CCND1—ocular cancer	1.6e-05	0.000188	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CDKN1B—ocular cancer	1.6e-05	0.000187	CbGpPWpGaD
Desipramine—HTR1A—GPCR downstream signaling—AKT1—ocular cancer	1.59e-05	0.000186	CbGpPWpGaD
Desipramine—HTR2C—GPCR downstream signaling—AKT1—ocular cancer	1.58e-05	0.000185	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GNAQ—ocular cancer	1.57e-05	0.000184	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CCND1—ocular cancer	1.57e-05	0.000184	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—MYC—ocular cancer	1.57e-05	0.000184	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—EP300—ocular cancer	1.56e-05	0.000183	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TGFB1—ocular cancer	1.56e-05	0.000183	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CDKN1A—ocular cancer	1.55e-05	0.000182	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MDM2—ocular cancer	1.54e-05	0.000181	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—EP300—ocular cancer	1.54e-05	0.00018	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CCND1—ocular cancer	1.53e-05	0.00018	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—AKT1—ocular cancer	1.53e-05	0.000179	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CCND1—ocular cancer	1.52e-05	0.000179	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MDM2—ocular cancer	1.52e-05	0.000178	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MDM2—ocular cancer	1.52e-05	0.000178	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CDKN1A—ocular cancer	1.52e-05	0.000178	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MDM2—ocular cancer	1.51e-05	0.000177	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—AKT1—ocular cancer	1.51e-05	0.000177	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MDM2—ocular cancer	1.51e-05	0.000177	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—MYC—ocular cancer	1.5e-05	0.000176	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TGFB1—ocular cancer	1.5e-05	0.000175	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MDM2—ocular cancer	1.49e-05	0.000175	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CDKN1A—ocular cancer	1.48e-05	0.000174	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—AKT1—ocular cancer	1.48e-05	0.000173	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CDKN1A—ocular cancer	1.47e-05	0.000173	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—EP300—ocular cancer	1.47e-05	0.000173	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—EP300—ocular cancer	1.44e-05	0.000169	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—AKT1—ocular cancer	1.44e-05	0.000169	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—EP300—ocular cancer	1.44e-05	0.000169	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—AKT1—ocular cancer	1.44e-05	0.000168	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—HRAS—ocular cancer	1.43e-05	0.000168	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—HRAS—ocular cancer	1.41e-05	0.000165	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—EP300—ocular cancer	1.41e-05	0.000165	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CDKN1B—ocular cancer	1.41e-05	0.000165	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—HRAS—ocular cancer	1.41e-05	0.000165	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—HRAS—ocular cancer	1.4e-05	0.000165	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—EP300—ocular cancer	1.4e-05	0.000164	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—HRAS—ocular cancer	1.4e-05	0.000164	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—AKT1—ocular cancer	1.39e-05	0.000163	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CDKN1B—ocular cancer	1.39e-05	0.000163	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—HRAS—ocular cancer	1.39e-05	0.000162	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CDKN1B—ocular cancer	1.38e-05	0.000162	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CDKN1B—ocular cancer	1.38e-05	0.000162	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CDKN1B—ocular cancer	1.38e-05	0.000161	CbGpPWpGaD
Desipramine—HTR2A—GPCR downstream signaling—AKT1—ocular cancer	1.37e-05	0.000161	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—AKT1—ocular cancer	1.37e-05	0.00016	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—AKT1—ocular cancer	1.36e-05	0.00016	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CDKN1B—ocular cancer	1.36e-05	0.00016	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—AKT1—ocular cancer	1.36e-05	0.000159	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—AKT1—ocular cancer	1.35e-05	0.000158	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CCND1—ocular cancer	1.35e-05	0.000158	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CCND1—ocular cancer	1.32e-05	0.000155	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CCND1—ocular cancer	1.32e-05	0.000155	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CCND1—ocular cancer	1.32e-05	0.000154	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CCND1—ocular cancer	1.31e-05	0.000154	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CDKN1A—ocular cancer	1.3e-05	0.000152	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CCND1—ocular cancer	1.3e-05	0.000152	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—ocular cancer	1.29e-05	0.000151	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MYC—ocular cancer	1.28e-05	0.000151	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TGFB1—ocular cancer	1.28e-05	0.00015	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CDKN1A—ocular cancer	1.28e-05	0.00015	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CDKN1A—ocular cancer	1.28e-05	0.00015	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CDKN1A—ocular cancer	1.27e-05	0.000149	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CDKN1A—ocular cancer	1.27e-05	0.000149	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—AKT1—ocular cancer	1.27e-05	0.000148	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CDKN1A—ocular cancer	1.26e-05	0.000147	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MYC—ocular cancer	1.26e-05	0.000147	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TGFB1—ocular cancer	1.25e-05	0.000147	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—AKT1—ocular cancer	1.25e-05	0.000146	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—AKT1—ocular cancer	1.24e-05	0.000146	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—EP300—ocular cancer	1.24e-05	0.000146	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—AKT1—ocular cancer	1.24e-05	0.000145	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EP300—ocular cancer	1.24e-05	0.000145	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—AKT1—ocular cancer	1.24e-05	0.000145	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—ocular cancer	1.23e-05	0.000144	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—HRAS—ocular cancer	1.23e-05	0.000144	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MYC—ocular cancer	1.23e-05	0.000144	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TGFB1—ocular cancer	1.23e-05	0.000144	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—AKT1—ocular cancer	1.22e-05	0.000143	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MYC—ocular cancer	1.22e-05	0.000143	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TGFB1—ocular cancer	1.22e-05	0.000143	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EP300—ocular cancer	1.22e-05	0.000143	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—EP300—ocular cancer	1.22e-05	0.000143	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EP300—ocular cancer	1.22e-05	0.000142	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EP300—ocular cancer	1.21e-05	0.000142	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EP300—ocular cancer	1.21e-05	0.000142	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EP300—ocular cancer	1.2e-05	0.00014	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—HRAS—ocular cancer	1.18e-05	0.000138	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—AKT1—ocular cancer	1.09e-05	0.000127	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MYC—ocular cancer	1.08e-05	0.000126	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TGFB1—ocular cancer	1.08e-05	0.000126	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MYC—ocular cancer	1.06e-05	0.000124	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MYC—ocular cancer	1.06e-05	0.000124	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TGFB1—ocular cancer	1.06e-05	0.000124	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TGFB1—ocular cancer	1.06e-05	0.000124	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MYC—ocular cancer	1.06e-05	0.000124	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—ocular cancer	1.06e-05	0.000124	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TGFB1—ocular cancer	1.05e-05	0.000123	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MYC—ocular cancer	1.05e-05	0.000123	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TGFB1—ocular cancer	1.05e-05	0.000123	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MYC—ocular cancer	1.04e-05	0.000122	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—AKT1—ocular cancer	1.04e-05	0.000122	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TGFB1—ocular cancer	1.04e-05	0.000122	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—ocular cancer	1.03e-05	0.000121	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—AKT1—ocular cancer	1.01e-05	0.000119	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—ocular cancer	1.01e-05	0.000118	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HRAS—ocular cancer	1.01e-05	0.000118	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—ocular cancer	1e-05	0.000118	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HRAS—ocular cancer	9.87e-06	0.000116	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HRAS—ocular cancer	9.65e-06	0.000113	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HRAS—ocular cancer	9.6e-06	0.000113	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—AKT1—ocular cancer	9.45e-06	0.000111	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—EP300—ocular cancer	9.39e-06	0.00011	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—AKT1—ocular cancer	9.31e-06	0.000109	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—EP300—ocular cancer	9.17e-06	0.000107	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—AKT1—ocular cancer	8.91e-06	0.000104	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—ocular cancer	8.86e-06	0.000104	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—AKT1—ocular cancer	8.73e-06	0.000102	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—ocular cancer	8.72e-06	0.000102	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—AKT1—ocular cancer	8.71e-06	0.000102	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—ocular cancer	8.7e-06	0.000102	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—ocular cancer	8.67e-06	0.000102	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—ocular cancer	8.64e-06	0.000101	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—EP300—ocular cancer	8.64e-06	0.000101	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—ocular cancer	8.56e-06	0.0001	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—AKT1—ocular cancer	8.52e-06	9.99e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—AKT1—ocular cancer	8.48e-06	9.93e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HRAS—ocular cancer	8.47e-06	9.93e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—HRAS—ocular cancer	8.34e-06	9.77e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HRAS—ocular cancer	8.32e-06	9.75e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HRAS—ocular cancer	8.29e-06	9.72e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HRAS—ocular cancer	8.27e-06	9.69e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HRAS—ocular cancer	8.19e-06	9.59e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—AKT1—ocular cancer	7.51e-06	8.8e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—AKT1—ocular cancer	7.48e-06	8.77e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—AKT1—ocular cancer	7.36e-06	8.63e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—AKT1—ocular cancer	7.36e-06	8.62e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—AKT1—ocular cancer	7.35e-06	8.61e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—AKT1—ocular cancer	7.32e-06	8.58e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—EP300—ocular cancer	7.32e-06	8.57e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—AKT1—ocular cancer	7.3e-06	8.55e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—AKT1—ocular cancer	7.23e-06	8.47e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—AKT1—ocular cancer	5.67e-06	6.65e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—EP300—ocular cancer	5.65e-06	6.62e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—AKT1—ocular cancer	5.54e-06	6.49e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—AKT1—ocular cancer	5.22e-06	6.12e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—AKT1—ocular cancer	4.42e-06	5.18e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—AKT1—ocular cancer	3.41e-06	4e-05	CbGpPWpGaD
